Cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income
Upper middle income: Cause of death, by non-communicable diseases, ages 0-4, female was 29.5% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 0-4.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income stood at 29.5%. That is the highest value across all 6 years on record.
That represents a change of up 1.0% on the previous year and up 22.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income peaked at 29.5% in 2021 and was at its lowest, 18.6%, in 2000.
That places Upper middle income 12th out of 47 groups with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income, year by year
| Year | % of total female deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 18.6% | — |
| 2010 | 24.2% | +29.9% |
| 2015 | 27.7% | +14.4% |
| 2019 | 29.2% | +5.6% |
| 2020 | 29.2% | -0.0% |
| 2021 | 29.5% | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.6% | 18.6% | 18.6% | 1 |
| 2010s | 27.0% | 24.2% | 29.2% | 3 |
| 2020s | 29.4% | 29.2% | 29.5% | 2 |
Countries ranked near Upper middle income
More health data for Upper middle income
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 1.94 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0359 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.71 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0413 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.11 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0394 units per person (2025)
- Population ages 30-34, female, annual growth rate -3.39 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income?
- Cause of death, by non-communicable diseases, ages 0-4, female in Upper middle income was 29.5% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, female recorded in Upper middle income?
- The highest recorded value was 29.5% in 2021.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, female recorded in Upper middle income?
- The lowest recorded value was 18.6% in 2000.
- How does Upper middle income rank for cause of death, by non-communicable diseases, ages 0-4, female?
- Upper middle income ranks 12th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, female rising or falling in Upper middle income?
- Over the last ten years it is up 22.0%. The long-run trend across the full record is rising.
- Where does this Upper middle income data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.